Search Results

By Syed Ali Abutalib, MD, and Courtney DiNardo, MD, MSCE  / May 10, 2025

Venetoclax-Based Therapy for Patients With Newly Diagnosed Acute Myeloid Leukemia

“Knowledge is like a lion; it cannot be gently embraced.” –South African Proverb Long-term efficacy and safety confirm that a hypomethylating agent and venetoclax is an improvement in the standard of care for patients with AML who are not eligible for intensive chemotherapy because of advanced age...